Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pseudomonas aeruginosa in NMIBC
NCT05975151Phase 2Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Oct 2023
- Primary completion
- Aug 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of pseudomonas aeruginosa injection in non-muscle-invasive bladder cancer (NMIBC), sponsored by Qilu Hospital of Shandong University. Started Oct 2023; status: recruiting.
02
Drugs
pseudomonas aeruginosa injection
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT05975151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05975151.